FDA ALERT - POTENTIAL NEUROLOGIC ADVERSE EVENTS WITH FLEA & TICK MEDICATIONS IN THE ISOXOZALINE CLAS

FDA ALERT - POTENTIAL NEUROLOGIC ADVERSE EVENTS WITH FLEA & TICK MEDICATIONS IN THE ISOXOZALINE CLAS

The FDA is alerting⚠️ pet owners & veterinarians of the potential for neurologic adverse events in dogs and cats when treated with Flea & Tick drugs that are in the isoxazoline class.

Bravecto (fluralaner) tablets for dogs

Bravecto (fluralaner) topical solution for cats and dogs

Bravecto Plus (fluralaner and moxidectin) topical solution for cats

Bravecto 1-month (fluralaner) tablets for dogs

Credelio (lotilaner) tablets for dogs and cats

Nexgard (afoxolaner) tablets for dogs

Simparica (sarolaner) tablets for dogs

Simparica Trio (sarolaner, moxidectin and pyrantel) tablets for dogs

Revolution Plus (selamectin and sarolaner) topical solution for cats

Good news Garden State Pet Center carries holistic alternatives for flea and tick management. Stop in and ask one of our knowledgeable associates about flea and tick products for your pets


Share this post



← Older Post Newer Post →


Leave a comment

Please note, comments must be approved before they are published.